After anti-BCR+IL-21 stimulation, both CD27– and CD27+ B cells from AP-CVID patients and remaining CVID induced lower Bcl-2 and Bcl-XL levels than controls (Fig. 7a, b). Here, BCL2L1 is linked to common variable immunodeficiency.